Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| New York Genome Center | RCV001837189 | SCV002097669 | uncertain significance | Developmental and epileptic encephalopathy, 64 | 2020-06-26 | criteria provided, single submitter | clinical testing | The homozygous c.1541A>G (p.His514Arg) variant identified in the RHOBTB2 gene substitutes a well conserved Histidine for Arginine at amino acid 514/728 (exon 6/10). This variant is absent from gnomAD suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict this variant to be Deleterious (Provean; score:-6.89) and Damaging (SIFT; score:0.001) to the function of the canonical transcript. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature. The p.His514 residue is within the second BTB domain of RHOBTB2 (UniProtKB:Q9BYZ6). While to our current knowledge individuals have not been reported with variants within the second BTB domain, missense variants in the first BTB domain and the linker region between the first and second BTB domains have been described in affected individualsin the literature [PMID:29276004; PMID:29768694; PMID:26740508]. The homozygous c.1541A>G (p.His514Arg) variant identified in the RHOBTB2 gene is reported here as a Variant of Uncertain Significance. |